Form 8-K - Current report:
SEC Accession No. 0001437749-24-030893
Filing Date
2024-10-08
Accepted
2024-10-08 17:02:18
Documents
15
Period of Report
2024-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20241006_8k.htm   iXBRL 8-K 23246
2 EXHIBIT 4.1 ex_730110.htm EX-4.1 11618
  Complete submission text file 0001437749-24-030893.txt   170394

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20241004.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20241004_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20241004_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20241004_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT dyai20241006_8k_htm.xml XML 2845
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 241360877
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)